|
Development Agreements (Details) (USD $)
|
12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 1 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
Dec. 31, 2011
Animas Corporation [Member]
|
Dec. 31, 2010
Animas Corporation [Member]
|
Jan. 31, 2009
Animas Corporation [Member]
|
Jan. 31, 2008
Animas Corporation [Member]
|
May 05, 2009
Edwards Lifesciences LLC [Member]
|
Dec. 31, 2011
Edwards Lifesciences LLC [Member]
|
Dec. 31, 2010
Edwards Lifesciences LLC [Member]
|
Dec. 31, 2009
Edwards Lifesciences LLC [Member]
|
Nov. 30, 2008
Edwards Lifesciences LLC [Member]
|
Jul. 31, 2009
Maximum [Member]
Animas Corporation [Member]
|
May 05, 2009
Maximum [Member]
Edwards Lifesciences LLC [Member]
|
Nov. 01, 2011
Maximum [Member]
Roche Diagnostics Operations [Member]
|
Nov. 01, 2011
Agreements With Roche Diagnostics Operations [Member]
Roche Diagnostics Operations [Member]
|
Nov. 01, 2011
Agreements With Roche Diagnostics Operations [Member]
Maximum [Member]
Roche Diagnostics Operations [Member]
|
Dec. 31, 2010
Manufacturing Line [Member]
Animas Corporation [Member]
|
May 31, 2011
Regulatory Body Approval [Member]
Animas Corporation [Member]
|
|
| Development Agreements [Line Items] | |||||||||||||||||||
| Joint commitment to offset development, clinical and regulatory expenses | $ 300,000 | $ 500,000 | $ 10,000,000 | $ 10,000,000 | $ 13,000,000 | $ 1,100,000 | $ 10,000,000 | $ 1,000,000 | |||||||||||
| Joint commitment upfront fee | 13,000,000 | ||||||||||||||||||
| Development grant and other revenue | 10,356,000 | 8,456,000 | 11,657,000 | 100,000 | 200,000 | 2,100,000 | 6,900,000 | ||||||||||||
| One time milestone payment, pending | 500,000 | ||||||||||||||||||
| One time milestone payment, received | 1,000,000 | 4,000,000 | |||||||||||||||||
| Additional payment received upon agreement of a development and regulatory plan | 500,000 | ||||||||||||||||||
| Development payment | 300,000 | ||||||||||||||||||
| Profit sharing percent maximum | 10.00% | ||||||||||||||||||
| Commercial sales royalty maximum | 6.00% | ||||||||||||||||||
| Additional milestones payments | 2,000,000 | ||||||||||||||||||
| Amount of money received related to regulatory approvals and manufacturing readiness | $ 12,000,000 | ||||||||||||||||||